•
Mar 31, 2023

IGM Biosciences Q1 2023 Earnings Report

Total Revenue
$522K
EPS
-$1.33
Previous year: -$1.53
-13.1%
R&D Expenses
$50.9M
G&A Expenses
$13M
Cash and Equivalents
$140M
Previous year: $75.4M
+85.9%
Free Cash Flow
-$54.9M
Previous year: -$41.9M
+31.2%
Total Assets
$463M
Previous year: $258M
+79.5%

IGM Biosciences

IGM Biosciences